Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)

Amichai Perlman; Rachel Goldstein; Lotan Choshen Cohen; Bruria Hirsh‑Raccah; David Hakimian; Ilan Matok; Yosef Kalish; Daniel E. Singer; Mordechai Muszkat

doi:10.1007/s40263-021-00844-7

Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)

Amichai Perlman
, Rachel Goldstein
, Lotan Choshen Cohen
, Bruria Hirsh‑Raccah
, David Hakimian
, Ilan Matok
, Yosef Kalish
, Daniel E. Singer
, Mordechai Muszkat

Research output: Contribution to journal › Comment/debate

Abstract

The article Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study, written by Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh‑Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E. Singer, Mordechai Muszkat, was originally published Online First without Open Access. After publication in volume 35, issue 3, page 305–316 the author decided to opt for Open Choice and to make the article an Open Access publication.

Original language	English
Pages (from-to)	919
Number of pages	1
Journal	CNS Drugs
Volume	35
Issue number	8
DOIs	https://doi.org/10.1007/s40263-021-00844-7
State	Published - 1 Aug 2021
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1007/s40263-021-00844-7

Fingerprint

Dive into the research topics of 'Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)'. Together they form a unique fingerprint.

Cite this

Perlman, A., Goldstein, R., Choshen Cohen, L., Hirsh‑Raccah, B., Hakimian, D., Matok, I., Kalish, Y., Singer, D. E., & Muszkat, M. (2021). Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z). CNS Drugs, 35(8), 919. https://doi.org/10.1007/s40263-021-00844-7

@article{547bcba8b79f4fc8938fd2e308c16e28,

title = "Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)",

abstract = "The article Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study, written by Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh‑Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E. Singer, Mordechai Muszkat, was originally published Online First without Open Access. After publication in volume 35, issue 3, page 305{\textendash}316 the author decided to opt for Open Choice and to make the article an Open Access publication.",

author = "Amichai Perlman and Rachel Goldstein and \{Choshen Cohen\}, Lotan and Bruria Hirsh‑Raccah and David Hakimian and Ilan Matok and Yosef Kalish and Singer, \{Daniel E.\} and Mordechai Muszkat",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021",

year = "2021",

month = aug,

day = "1",

doi = "10.1007/s40263-021-00844-7",

language = "English",

volume = "35",

pages = "919",

journal = "CNS Drugs",

issn = "1172-7047",

publisher = "Adis",

number = "8",

}

Perlman, A, Goldstein, R, Choshen Cohen, L, Hirsh‑Raccah, B, Hakimian, D, Matok, I, Kalish, Y, Singer, DE & Muszkat, M 2021, 'Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)', CNS Drugs, vol. 35, no. 8, pp. 919. https://doi.org/10.1007/s40263-021-00844-7

Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z). / Perlman, Amichai; Goldstein, Rachel; Choshen Cohen, Lotan et al.
In: CNS Drugs, Vol. 35, No. 8, 01.08.2021, p. 919.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)

AU - Perlman, Amichai

AU - Goldstein, Rachel

AU - Choshen Cohen, Lotan

AU - Hirsh‑Raccah, Bruria

AU - Hakimian, David

AU - Matok, Ilan

AU - Kalish, Yosef

AU - Singer, Daniel E.

AU - Muszkat, Mordechai

PY - 2021/8/1

Y1 - 2021/8/1

N2 - The article Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study, written by Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh‑Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E. Singer, Mordechai Muszkat, was originally published Online First without Open Access. After publication in volume 35, issue 3, page 305–316 the author decided to opt for Open Choice and to make the article an Open Access publication.

AB - The article Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study, written by Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh‑Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E. Singer, Mordechai Muszkat, was originally published Online First without Open Access. After publication in volume 35, issue 3, page 305–316 the author decided to opt for Open Choice and to make the article an Open Access publication.

UR - https://www.scopus.com/pages/publications/85111867480

U2 - 10.1007/s40263-021-00844-7

DO - 10.1007/s40263-021-00844-7

M3 - Comment/debate

C2 - 34342849

SN - 1172-7047

VL - 35

SP - 919

JO - CNS Drugs

JF - CNS Drugs

IS - 8

ER -

Perlman A, Goldstein R, Choshen Cohen L, Hirsh‑Raccah B, Hakimian D, Matok I et al. Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z). CNS Drugs. 2021 Aug 1;35(8):919. doi: 10.1007/s40263-021-00844-7

Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this